Subscription and demo access

About Interfax
Press Releases
Products & Services
Contact us
Customer Login


09/20 19:25   U.S. national hospitalized with knife injuries from currency exchange office in Tbilisi
09/20 19:24   Ukraine's decision not to work on UN resolution shows Kyiv's indifference to int'l obligations - DPR
09/20 19:22   Poroshenko urges UN SC to deploy peacekeeping mission in Donbas sooner rather than later (Part 2)
09/20 19:22   Central Elections Commission receives some 3,000 complaints during recent election campaign, almost half from Moscow region
09/20 19:21   Ukraine fails to fulfill obligations in withdrawal in Donbas' Stanytsia Luhanska again - Gryzlov (Part 2)
09/20 19:19   John Tefft to leave Russia by end of September - U.S. Embassy
09/20 19:18   Russian deputy FM, UK ambassador discuss Middle East settlement, fight against terrorism
09/20 19:16   Lavrov meeting with OSCE Secretary General Greminger
09/20 19:16   Central Elections Commission to discuss proposal to scrap or considerably limit early voting
09/20 19:15   Putin thanks Russian Jewish community leaders for defending historical truth  |  Interfax news  |  Pharmstandard, Millhouse close deal to acquire...

News headlines

July 25, 2014 09:25

Pharmstandard, Millhouse close deal to acquire stakes in Biocad Holding

MOSCOW. July 25 (Interfax) - Pharmstandard (MOEX: PHST), a major Russian drug maker, and Millhouse have completed individual acquisitions of shares in Biocad Holding Ltd., the principal shareholder of St. Petersburg-based biotech company CJSC Biocad, the companies said in a joint statement.

Pharmstandard acquired a 20% stake in Biocad Holding Ltd., while a company affiliated with Millhouse acquired 50%.

Pharmstandard financed the acquisition with its own money, the press release states.

Biocad CEO and founder Dmitry Morozov will retain a 30% stake in Biocad Holding Ltd and will continue to run the company with his management team, the statement said.

Biocad develops, manufactures and promotes its own and generic drugs to treat illnesses in the areas of urology, gynecology, dermatovenereology, oncology and hematology, as well as autoimmune and infectious diseases. The company has a line of 14 drugs.

"Millhouse and Pharmstandard have a successful track record of working together to develop leaders in the pharmaceutical market. The companies previously cooperated on the acquisitions of ICN Pharmaceuticals, Inc. and CJSC Masterlek, and on Pharmstandard's initial public offering," the press release said.

It was reported earlier that in this deal the companies would buy the stake of Gazprombank (MOEX: GZPR), which acquired a controlling stake in the pharmaceutical company in 2011 for about $250 million-$300 million, as well as part of the stake held by company management.

RMG senior analyst Ksenia Arutyunova valued all of Biocad at $1 billion. Therefore, the stakes acquired by Pharmstandard and Millhouse are worth $200 million and $500 million respectively.

Millhouse is acting as a financial investor, who will divest the stake at some point, Arutyunova said, adding that this stake could be bought by Pharmstandard.

Biocad currently sells its products in Russia and other CIS countries. The company has offices in Ukraine, Belarus, Brazil, China, India and the United States. Biocad is also setting up production of drugs based on monoclonal antibodies in Brazil.

Biocad has two factories in Russia - in the Moscow Region and in the St. Petersburg special economic zone. The company had revenue of 3 billion rubles in 2013.

It was reported earlier that U.S. drug makers Pfizer and Amgen were interested in buying Biocad. The company was valued at $0.75 billion-$1 billion.

Vp of

(Our editorial staff can be reached at

You can access a demo version of, receive more information about or subscribe to Interfax publications by filling in and returning the form below. We also have dozens of reports in the Russian language, please indicate if you are interested.



First name:


Last name:


Central Asia & Caucasus Business Weekly
Central Asia General Newswire
Global Gas Analytics
Global Natural Gas Daily
Interfax Via Bloomberg Terminal
Kazakhstan General Newswire
Kazakhstan Mining Weekly
Kazakhstan Oil & Gas Weekly
Russia & CIS Announcements
Russia & CIS Banking and Finance Weekly
Russia & CIS Business and Financial Daily
Russia & CIS Business and Financial Newswire
Russia & CIS Business and Investment Weekly
Russia & CIS Business Law Weekly
Russia & CIS Business news
Russia & CIS Defense Industry Weekly
Russia & CIS Diplomatic Panorama
Russia & CIS Energy Daily
Russia & CIS Energy Newswire
Russia & CIS Events Calendar
Russia & CIS Food and Agriculture Weekly
Russia & CIS General Newswire
Russia & CIS Headline News
Russia & CIS Insurance Weekly
Russia & CIS IT and Telecom Weekly
Russia & CIS Metals and Mining Weekly
Russia & CIS Military Daily
Russia & CIS Military Newswire
Russia & CIS Military Weekly
Russia & CIS Oil and Gas Weekly
Russia & CIS Presidential Bulletin
Russia & CIS Statistics Weekly
Russia Health & Pharmaceuticals
Russia Market Roundup
Russia Press Review
Ukraine Business Daily
Ukraine Business Weekly
Ukraine General Newswire
Please enter the digits from picture in the box below:

September 20, 2017
John Tefft to leave Russia by end of September - U.S. Embassy
Russian deputy FM, UK ambassador discuss Middle East settlement, fight against terrorism
Lavrov meeting with OSCE Secretary General Greminger
Central Elections Commission to discuss proposal to scrap or considerably limit early voting
Putin thanks Russian Jewish community leaders for defending historical truth
Three Afghan men try to illegally enter Norway from Murmansk region
First Deputy Health Minister Kagramanian appointed Yaroslavl region's Federation Council rep
Saboteurs detained in LPR involved in several crimes - LPR prosecution
DPR says Ukraine is delaying negotiations on prisoner exchange
Next session of contact group on Ukraine in Minsk to be held on Oct 4
Kazakhstan resident who fought for Donbas militia gets 3.5-year suspended sentence
Astana surprised by Bishkek's reaction to Nazarbayev's meeting with Kyrgyz presidential candidate
 more headlines 


Filipino Ambassador to Russia Carlos Sorreta has given an interview to Interfax in which he speaks about prospects for Russian-Filipino cooperation in the military-technical sphere, as well possible cooperation on anti-terrorism, energy, investments and tourism.

Sudanese State Minister for Foreign Affairs Atta Elmanan Bakhit has given an interview to Interfax during his visit to Moscow in which he speaks about a visit of Sudanese President Omar al-Bashir to Russia, bilateral Russian-Sudanese economic and military cooperation and describes sanctions in the global politics as "immoral and illegal".

Secretary General of the League of Arab States has given an interview with Interfax in the wake of his negotiations with Russian Foreign Minister Sergei Lavrov in which he speaks about the participation of Arab countries in the Astana process, Russia‘s political and military role in Syria, as well as prospects for resuming Syria‘s membership in the Arab League.


 ©   1991—2017   Interfax Information Service. All rights reserved.
contact information   |   Interfax offices   |   made by web.finmarket

News and other data on this site are provided for information purposes only, and are not intended for republication or redistribution. Republication or redistribution of Interfax content, including by framing or similar means, is expressly prohibited without the prior written consent of Interfax.

Browse other Interfax sites:   |   IFX.RU   |   Interfax Group   Rambler's Top100